IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise. (March 2023)

Record Type:: Journal Article
Title:: IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise. (March 2023)
Main Title:: IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise
Authors:: Wang, W.
Chen, R.
Davies, A. Lloyd
Guo, J.
Jensen, T. Bo
Li, Y.
Luo, B.
Ye, X.
Zhang, K.
Ning, G.
Abstract:
Is Part Of:: Diabetes research and clinical practice. Volume 197(2023)Supplement 1
Journal:: Diabetes research and clinical practice
Issue:: Volume 197(2023)Supplement 1
Issue Display:: Volume 197, Issue 1 (2023)
Year:: 2023
Volume:: 197
Issue:: 1
Issue Sort Value:: 2023-0197-0001-0000
Page Start:
Page End:
Publication Date:: 2023-03
Subjects:: Diabetes -- Periodicals
Diabetes Mellitus -- Periodicals
616.462
Journal URLs:: http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01688227 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01688227 ↗
http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.diabres.2023.110316 ↗
Languages:: English
ISSNs:: 0168-8227
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3579.603700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26500.xml